COGT

Quote

Short

News

Articles

Message Board

Cogent Biosciences Inc. (NASDAQ : COGT ) News

Cogent Biosciences Inc. (NASDAQ: COGT) News Releases

COGT News Releases

June 02, 2026 10:10:32 am

SeekingAlpha

These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations

June 01, 2026 09:24:44 am

24/7 Market News

Lilly's Phase 3 Breakthrough Ignites Race for the Next Cancer Stock Breakout

May 30, 2026 08:00:00 am

GlobeNewswire

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

May 28, 2026 09:12:57 am

SeekingAlpha

Cogent Bio granted FDA priority review for lead asset in tumor indication

May 28, 2026 08:00:00 am

GlobeNewswire

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST

May 27, 2026 08:00:00 am

GlobeNewswire

Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference

May 24, 2026 04:13:22 pm

SeekingAlpha

SA Asks: What are the most attractive biotech stocks right now?

May 15, 2026 04:48:11 pm

SeekingAlpha

Stanley Druckenmiller's Duquesne initiates stake in AVGO, dumps GOOGL among Q1 moves

May 12, 2026 09:30:00 am

GlobeNewswire

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

May 05, 2026 08:06:24 am

SeekingAlpha

Cogent Biosciences reports Q1 results

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account